📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Affinium Pharmaceuticals

1.1 - Company Overview

Affinium Pharmaceuticals Logo

Affinium Pharmaceuticals

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of specialty pharmaceutical research and development focused on novel anti-infective medicines, advancing FASII antibacterial programs as a new antibiotic franchise with potential for multiple products targeting the FASII pathway, supported by a broad base of long-term intellectual property.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Affinium Pharmaceuticals

NanoViricides Logo

NanoViricides

HQ: United States Website
  • Description: Provider of nanomedicine-based antiviral therapeutics, developing broad-spectrum candidates including NV-387 (RSV, smallpox, mpox, influenza A), NV-CoV-2 for COVID-19 and potentially long COVID (Phase 1a/1b), NV-CoV-2-R with remdesivir, and NV-HHV-1 for shingles rash, leveraging the TheraCour platform and the HerpeCide program for herpes infections (cold sores, genital ulcers, keratitis).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full NanoViricides company profile →
Abivax Logo

Abivax

HQ: France Website
  • Description: Provider of clinical-stage biotechnology therapies that mobilize the body's natural immune machinery to treat autoimmune diseases, viral infections, and cancer, including obefazimod for ulcerative colitis (Phase 3), planned Phase 2b for Crohn's disease, exploration as combination therapy for ulcerative colitis in preclinical studies, and nonclinical evaluation for additional chronic inflammatory indications.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Abivax company profile →
iosBio Logo

iosBio

HQ: United Kingdom Website
  • Description: Provider of thermally stable oral vaccine platforms and services, offering vaccine manufacturing, distribution, and delivery. Its OraPro technology uses viral vectors to deliver capsule-based vaccines to the GI tract, enabling mucosal and systemic immunity without cold-chain storage. Products include OraPro and OraPro-Covid-19, an at-home oral vaccine targeting S and N proteins.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full iosBio company profile →
Oxsed Logo

Oxsed

HQ: United Kingdom Website
  • Description: Provider of accurate and rapid testing worldwide to minimize the impact of disease on individuals and communities.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Oxsed company profile →
Coulter Pharmaceutical Logo

Coulter Pharmaceutical

HQ: United States Website
  • Description: Provider of immunotherapeutics aimed at treating and preventing autoimmune diseases, cancer, and infectious diseases by understanding and directing the immune system; conducted preclinical development programs including the BEXXAR therapy and MELACINE vaccine.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Coulter Pharmaceutical company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Affinium Pharmaceuticals

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Affinium Pharmaceuticals

2.2 - Growth funds investing in similar companies to Affinium Pharmaceuticals

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Affinium Pharmaceuticals

4.2 - Public trading comparable groups for Affinium Pharmaceuticals

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Affinium Pharmaceuticals

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Affinium Pharmaceuticals

What does Affinium Pharmaceuticals do?

Affinium Pharmaceuticals is a provider of specialty pharmaceutical research and development focused on novel anti-infective medicines, advancing FASII antibacterial programs as a new antibiotic franchise with potential for multiple products targeting the FASII pathway, supported by a broad base of long-term intellectual property.

Who are Affinium Pharmaceuticals's competitors?

Affinium Pharmaceuticals's competitors and similar companies include NanoViricides, Abivax, iosBio, Oxsed, and Coulter Pharmaceutical.

Where is Affinium Pharmaceuticals headquartered?

Affinium Pharmaceuticals is headquartered in United States.

How many employees does Affinium Pharmaceuticals have?

Affinium Pharmaceuticals has 1,000 employees 🔒.

When was Affinium Pharmaceuticals founded?

Affinium Pharmaceuticals was founded in 2010 🔒.

What sector and industry vertical is Affinium Pharmaceuticals in?

Affinium Pharmaceuticals is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Affinium Pharmaceuticals

Who are the top strategic acquirers in Affinium Pharmaceuticals's sector and industry

Top strategic M&A buyers and acquirers in Affinium Pharmaceuticals's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Affinium Pharmaceuticals?

Top strategic M&A buyers groups and sectors for Affinium Pharmaceuticals include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Affinium Pharmaceuticals's sector and industry vertical

Which are the top PE firms investing in Affinium Pharmaceuticals's sector and industry vertical?

Top PE firms investing in Affinium Pharmaceuticals's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Affinium Pharmaceuticals's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Affinium Pharmaceuticals's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Affinium Pharmaceuticals's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Affinium Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Affinium Pharmaceuticals's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Affinium Pharmaceuticals?

The key public trading comparables and valuation benchmarks for Affinium Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Affinium Pharmaceuticals for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Affinium Pharmaceuticals with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Affinium Pharmaceuticals's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Affinium Pharmaceuticals with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Affinium Pharmaceuticals's' sector and industry vertical?

Access recent funding rounds and capital raises in Affinium Pharmaceuticals's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Affinium Pharmaceuticals

Launch login modal Launch register modal